PharmaRoth Labs Inc. Stock Analysis ROTH
PharmaRoth Labs, Inc. focuses on diabetes prevention and treatments. The firm is engaged in the production, marketing, and distribution of Sucanon, a clinically-tested herbal-based nutraceutical treatment for type II diabetes. Sucanon is a medication that helps the body make better use of its own insulin, the hormone that controls blood sugar levels.
Read More PharmaRoth Labs Inc (ROTH) Chart
Key Statistics of PharmaRoth Labs Inc (ROTH)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
1500.00P/E Ratio (TTM)
-52 Week Range
Market Cap
351.20Avg. Volume
7000.00Dividend Yield
-Financial Metrics & Statements of PharmaRoth Labs Inc (ROTH)
FAQ's for PharmaRoth Labs Inc (ROTH)
- According to Musaffa’s Shariah screening methodology, PharmaRoth Labs Inc (ROTH) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.